Daniel Yeomanson
Impact in
-
- Neuroblastoma Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cell death mechanisms and regulation 2
- Renal and related cancers 2
-
- Neuroblastoma Research and Treatments 5
- Co-authors
- David King (5 shared papers)Helen E. Bryant (3 shared papers)Anton Mayer (1 shared paper)Polly Gravells (2 shared papers)David S. King (2 shared papers)Adam Glaser (2 shared papers)Sheila Lane (2 shared papers)Daniel Connolly (1 shared paper)
- Journals
- Archives of Disease in Childhood (3 papers)BMJ Supportive & Palliative Care (2 papers)Journal of Pediatric Hematology/Oncology (2 papers)Journal of Adolescent and Young Adult Oncology (1 paper)Oncotarget (1 paper)
- Partner nations
- United KingdomItalyDenmark
In The Last Decade
Daniel Yeomanson
16 papers receiving 298 citations
Peers
Comparison fields: 5 of 73
- Neurology 64
- Cancer Research 55
- Molecular Biology 149
- Oncology 50
- Genetics 18
Countries citing papers authored by Daniel Yeomanson
This map shows the geographic impact of Daniel Yeomanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Yeomanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Yeomanson more than expected).
Fields of papers citing papers by Daniel Yeomanson
This network shows the impact of papers produced by Daniel Yeomanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Yeomanson. The network helps show where Daniel Yeomanson may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Yeomanson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 207 | |
| 2 | 2020 | 23 | |
| 3 | 2021 | 11 | |
| 4 | 2012 | 10 | |
| 5 | 2021 | 9 | |
| 6 | 2013 | 9 | |
| 7 | 2014 | 9 | |
| 8 | 2017 | 8 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 3 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 2 | |
| 13 | 2012 | 2 | |
| 14 | Rhabdomyosarcoma in All Age Groups at the Jos University Teaching Hospital. | 2019 | 1 |
| 15 | 2012 | 1 | |
| 16 | 2012 | 1 |
About Daniel Yeomanson
Daniel Yeomanson is a scholar working on Molecular Biology, Neurology, Oncology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 303 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Cell death mechanisms and regulation (2 papers), Renal and related cancers (2 papers), Reproductive Biology and Fertility (2 papers), PARP inhibition in cancer therapy (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Sympathectomy and Hyperhidrosis Treatments (1 paper). The work is most often cited by research in Neurology (64 citations), Cancer Research (55 citations), Molecular Biology (149 citations), Oncology (50 citations) and Genetics (18 citations). Daniel Yeomanson has collaborated with scholars based in United Kingdom, Italy and Denmark. Frequent co-authors include David King, Helen E. Bryant, Anton Mayer, Polly Gravells, David S. King, Adam Glaser, Sheila Lane, Daniel Connolly, Sally L. George and Helen M. Picton. Their work appears in journals such as Archives of Disease in Childhood, BMJ Supportive & Palliative Care, Journal of Pediatric Hematology/Oncology, Journal of Adolescent and Young Adult Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.